Imperato A, Mulas A, Di Chiara G
Institute of Experimental Pharmacology and Toxicology, University of Cagliari, Italy.
Eur J Pharmacol. 1987 Oct 6;142(1):177-81. doi: 10.1016/0014-2999(87)90672-8.
SCH 23390, from doses of 0.012 mg/kg s.c., dose dependently stimulated the release of dopamine (DA) and the output of its metabolites, dihydroxyphenylacetic acid and homovanillic acid, in the dorsal caudate of freely moving rats implanted with transcerebral dialysis fibers. SKF 38393 failed to modify DA release and metabolism at doses of 5, 10 and 25 mg/kg s.c. but at 25 mg/kg s.c. it abolished the effect of 0.025 mg/kg of SCH 23390. Administration of gamma-butyrolactone (700 mg/kg s.c.), which blocks the firing of DA neurons, prevented the effect of 0.050 mg/kg s.c. SCH 23390. The results indicate that D-1 receptors control the release of DA, probably through stimulation of the firing of DA neurons.
SCH 23390,皮下注射剂量为0.012毫克/千克时,可剂量依赖性地刺激自由活动的、植入经脑透析纤维的大鼠背侧尾状核中多巴胺(DA)的释放及其代谢产物二羟基苯乙酸和高香草酸的排出。皮下注射剂量为5、10和25毫克/千克时,SKF 38393未能改变DA的释放和代谢,但皮下注射剂量为25毫克/千克时,它消除了0.025毫克/千克SCH 23390的作用。皮下注射γ-丁内酯(700毫克/千克)可阻断DA神经元的放电,从而阻止了皮下注射0.050毫克/千克SCH 23390的作用。结果表明,D-1受体可能通过刺激DA神经元的放电来控制DA的释放。